Similar Hematologic Effects of Long‐Term Linezolid and Vancomycin Therapy in a Prospective Observational Study of Patients with Orthopedic Infections
Open Access
- 15 April 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (8) , 1058-1064
- https://doi.org/10.1086/382356
Abstract
Linezolid is an alternative to vancomycin for the long-term treatment of gram-positive bacterial orthopedic infections because of its antibacterial sKeywords
This publication has 22 references indexed in Scilit:
- Linezolid Does Not Increase the Risk of Thrombocytopenia in Patients with Nosocomial Pneumonia: Comparative Analysis of Linezolid and Vancomycin UseClinical Infectious Diseases, 2003
- From evidence-based guideline methodology to quality of care standardsJournal of Antimicrobial Chemotherapy, 2003
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002
- Thrombocytopenia Secondary to Linezolid Administration: What Is the Risk?Clinical Infectious Diseases, 2002
- Linezolid‐Induced PancytopeniaClinical Infectious Diseases, 2002
- Linezolid‐Induced Pure Red Blood Cell AplasiaClinical Infectious Diseases, 2002
- Linezolid and Reversible MyelosuppressionPublished by American Medical Association (AMA) ,2001
- LinezolidDrugs, 2001
- Use of Linezolid, an Oxazolidinone, in the Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsClinical Infectious Diseases, 2000
- Vancomycin-Induced Neutropenia Treated with Granulocyte Colony-Stimulating Factor During Home Intravenous Infusion TherapyClinical Infectious Diseases, 1996